CA2324853C - Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain - Google Patents

Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain Download PDF

Info

Publication number
CA2324853C
CA2324853C CA2324853A CA2324853A CA2324853C CA 2324853 C CA2324853 C CA 2324853C CA 2324853 A CA2324853 A CA 2324853A CA 2324853 A CA2324853 A CA 2324853A CA 2324853 C CA2324853 C CA 2324853C
Authority
CA
Canada
Prior art keywords
tnf
antibody
antigen
human
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2324853A
Other languages
English (en)
Other versions
CA2324853A1 (fr
Inventor
Junming Le
Jan Vilcek
Peter E. Daddona
John Ghrayeb
David M. Knight
Scott A. Siegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Janssen Biotech Inc
Original Assignee
Centocor Inc
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc, New York University NYU filed Critical Centocor Inc
Priority to CA2736076A priority Critical patent/CA2736076A1/fr
Priority claimed from CA002106299A external-priority patent/CA2106299C/fr
Publication of CA2324853A1 publication Critical patent/CA2324853A1/fr
Application granted granted Critical
Publication of CA2324853C publication Critical patent/CA2324853C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2324853A 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain Expired - Lifetime CA2324853C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2736076A CA2736076A1 (fr) 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67082791A 1991-03-18 1991-03-18
US07/670,827 1991-03-18
CA002106299A CA2106299C (fr) 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002106299A Division CA2106299C (fr) 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2736076A Division CA2736076A1 (fr) 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Publications (2)

Publication Number Publication Date
CA2324853A1 CA2324853A1 (fr) 1992-09-19
CA2324853C true CA2324853C (fr) 2011-06-14

Family

ID=25676648

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2324853A Expired - Lifetime CA2324853C (fr) 1991-03-18 1992-03-18 Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Country Status (1)

Country Link
CA (1) CA2324853C (fr)

Also Published As

Publication number Publication date
CA2324853A1 (fr) 1992-09-19

Similar Documents

Publication Publication Date Title
EP0610201B1 (fr) Anticorps monoclonaux et chimeres diriges specifiquement contre le facteur humain de necrose de tumeurs
US7227003B2 (en) Anti-TNF antibody fragments
US5656272A (en) Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
US5919452A (en) Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
US7166284B2 (en) Methods of treating joint inflammation with anti-TNF antibodies
US7138118B2 (en) Methods of treating rheumatoid arthritis with anti-TNF antibodies
CA2324853C (fr) Anticorps monoclonaux et chimeriques specifiques du facteur de necrose tumorale humain

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry